Home › Funds › Geneos Wealth Management Inc. › USMV

Geneos Wealth Management Inc. position in USMV

ISHARES TR

Geneos Wealth Management Inc. reported holding 1,193,564 shares of USMV (ISHARES TR) in its Q3 2026 13F filing — a position valued at US$116.3M, representing 2.19% of its reported portfolio and ranking #3 among its reported holdings. Geneos Wealth Management Inc. has disclosed USMV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.19M sh
Reported value held$116.30M
Portfolio Weight2.19%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Geneos Wealth Management Inc.'s USMV position evolved

Geneos Wealth Management Inc. first disclosed a stake in USMV in Q3 2023 at 526,208 shares (US$38.1M). The position peaked in Q3 2026 at 1,193,564 shares, worth US$116.3M. Across 13 filings, Geneos Wealth Management Inc. increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,193,564 shares valued at US$116.3M — an increase of 16,296 shares quarter over quarter.. Notable position changes include a 99% increase in Q1 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 526.21K $38.09M New
Q4 2023 518.68K $40.47M Reduce
Q1 2024 521.61K $43.60M Add
Q2 2024 545.90K $45.83M Add
Q3 2024 548.46K $50.08M Hold
Q4 2024 554.00K $49.19M Add
Q1 2025 568.52K $53.25M Add
Q2 2025 560.63K $52.63M Reduce
Q3 2025 549.63K $52.29M Reduce
Q4 2025 573.79K $54.03M Add
Q1 2026 1.14M $106.05M Add
Q2 2026 1.18M $113.56M Add
Q3 2026 1.19M $116.30M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About USMV and 13F data

USMV (ISHARES TR) is a company whose sector is not yet classified in our data. 17 other funds we track also report a position in USMV — the largest reported positions include RAYMOND JAMES FINANCIAL INC (US$1.46B), WEALTH ENHANCEMENT ADVISORY SERVICES, LLC (US$496.4M), Catalyst Capital Advisors LLC (US$457.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding USMV

All USMV fund holders →

FAQ

How long has Geneos Wealth Management Inc. held USMV?

Geneos Wealth Management Inc. has disclosed USMV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Geneos Wealth Management Inc.'s current position in USMV?

As of Q3 2026, Geneos Wealth Management Inc. holds 1.19M shares of USMV (ISHARES TR), valued at $116.30M, representing 2.19% of its reported portfolio and ranking #3.

Has Geneos Wealth Management Inc. been buying or selling USMV?

In the latest 13F filing (Q3 2026), Geneos Wealth Management Inc. increased its position in USMV. The position peaked in Q3 2026 at 1.19M shares.

Which other funds hold USMV?

Other major institutional holders of USMV include RAYMOND JAMES FINANCIAL INC, WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, Catalyst Capital Advisors LLC, among 17 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.